Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 19, 2006

Bentley Inks Deal with Cardinal Health

  • Bentley Pharmaceuticals secured capacity at Cardinal Health’s new North Raleigh, NC-based facility for the scaleup and manufacture of clinical supplies of Bentley’s intranasal insulin product candidate.

    The product candidate utilizes Bentley’s CPE-215® drug delivery technology to deliver insulin directly through diabetic patients’ nasal mucosa using a nasal spray.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »